Ricardo D. Parrondo, MD, discusses the CARTITUDE-4 trial of cilta-cel in lenalidomide-refractory multiple myeloma.
Dr Parrondo on the Use of Cilta-Cel in Lenalidomide-Refractory Multiple Myeloma
by | Mar 28, 2024 | Uncategorized | 0 comments
by | Mar 28, 2024 | Uncategorized | 0 comments
Ricardo D. Parrondo, MD, discusses the CARTITUDE-4 trial of cilta-cel in lenalidomide-refractory multiple myeloma.